Rituximab based therapy followed by autologous stem cell transplantation leads to superior outcome and high rates of PCR negativity in patients with indolent B-cell lymphoproliferative disorders

Author： Cerny Jan   Trneny Marek   Slavickova Alena   Pytlik Robert   Salkova Jana   Valkova Veronika   Liu Qin   Houghton JeanMarie   Klener Pavel  

Publisher： Maney Publishing

ISSN： 1024-5332

Source： Hematology, Vol.14, Iss.4, 2009-08, pp. : 187-197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Early lymphocyte recovery following autologous peripheral stem cell transplantation is associated with better survival in younger patients with lymphoproliferative disorders

By Boulassel M. R.   Herr A. L.   Deb Edwardes M. D.   Galal A.   Lachance S.   Laneuville P.   Routy J. P.  

Hematology, Vol. 11, Iss. 3, 2006-06 ,pp. : 165-170

Maney Publishing

Access to resources Recommend Favorite

The hyper-CVAD–rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma

By Ritchie D.   Seymour J.   Grigg A.   Roberts A.   Hoyt R.   Thompson S.   Szer J.   Prince H.  

Annals of Hematology, Vol. 86, Iss. 2, 2007-02 ,pp. : 101-105

Springer Publishing Company

Access to resources Recommend Favorite

Rituximab added to an intensified salvage chemotherapy program followed by autologous stem cell transplantation improved the outcome in relapsed and refractory aggressive non-Hodgkin lymphoma

By Sieniawski Michal   Staak Oliver   Glossmann Jan-Peter   Reineke Thorsten   Scheuß Helena   Diehl Volker   Engert Andreas   Josting Andreas  

Annals of Hematology, Vol. 86, Iss. 2, 2007-02 ,pp. : 107-115

Springer Publishing Company

Access to resources Recommend Favorite

Rituximab therapy increased post-transplant cytomegalovirus complications in Non-Hodgkin’s lymphoma patients receiving autologous hematopoietic stem cell transplantation

By Lee Ming-Yang  

Annals of Hematology, Vol. 87, Iss. 4, 2008-04 ,pp. : 285-289

Springer Publishing Company

Access to resources Recommend Favorite

Effect of rituximab on the long-term outcome after high-dose therapy for relapsed B-cell non-Hodgkin’s lymphoma

By Hess Georg   Flohr Thomas   Kolbe Karin   Bonn Sarah   Schuler Martin   Derigs Hans   Huber Christoph  

Annals of Hematology, Vol. 85, Iss. 11, 2006-11 ,pp. : 769-779

Springer Publishing Company

Access to resources Recommend Favorite